
Congress trades
bluebird bio, Inc. (BLUE)
NASDAQ · Healthcare · 8 congress trades · last filed 6 years agono longer trading under this ticker
About bluebird bio, Inc.
from the company's filings and listing, as of Oct 21, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- -
- Employees
- 248
- Listed since
- Jun 19, 2013
- Market value
- $48.7Mlast quoted Jun 2, 2025
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2025reported May 14, 2025 | -$3.74 | -$3.29 | $30.0M | $38.7M | EPS missRevenue miss |
| Q4 FY2024reported Mar 27, 2025 | -$5.60 | -$6.15 | $25.3M | $27.2M | EPS beatRevenue miss |
| Q3 FY2024reported Nov 14, 2024 | -$6.20 | -$7.28 | $10.6M | $18.1M | EPS beatRevenue miss |
| Q2 FY2024reported Aug 14, 2024 | -$8.40 | -$7.28 | $16.1M | $24.3M | EPS missRevenue miss |
| Q1 FY2024reported May 9, 2024 | -$7.60 | n/a | $18.6M | $19.3M | EPS n/aRevenue miss |
| Q4 FY2023reported Mar 26, 2024 | -$11.80 | n/a | $7.8M | $16.8M | EPS n/aRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A figure or flag reads n/a when a number is missing, or when the figure failed our check against the company's other quarters, its own filings and its share splits, and was left out. An estimate is a forecast made by analysts, not a company target.
Congress trades in BLUE
8 disclosures of 8 on record · median 22d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Dec 10, 2020 | Dec 28, 2020 | 18d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Dec 11, 2020 | Dec 28, 2020 | 17d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Jul 15, 2020 | Jul 24, 2020 | 9d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Apr 27, 2020 | May 28, 2020 | 31d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Sep 16, 2019 | Oct 16, 2019 | 30d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Jun 3, 2019 | Jul 11, 2019 | 38d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Dec 17, 2018 | Jan 11, 2019 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jun 2, 2025 | Oct 25, 2018 | Nov 9, 2018 | 15d |
We hold no closing prices for any row shown here, so no move is shown. Not investment advice.
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in BLUE, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded BLUE?
Lois Frankel and Ro Khanna disclosed BLUE transactions in the filings shown here.
How quickly are BLUE trades disclosed?
Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 27, 2026.
